Nigerian patients suffering from blood cancers now have new treatment options through CAR-T Cell Therapy but they face challenges in receiving this therapy within their home country. The therapy is expensive, specialised facilities are limited, and long waiting times add to the challenge. Families in most countries need to spend large amounts of money because CAR-T treatment is currently only available in USA and European countries. India is a preferred choice for CART-T Cell therapy for Nigerian patients because the country provides advanced cancer treatment through its skilled medical professionals and internationally accredited hospitals at lower prices. People from abroad choose India as their trusted destination for CAR-T Cell Therapy because the country maintains an ethical approach to treatment and patient care.
Why Nigerian Patients Prefer India for CAR-T Cell Therapy
Nigerian patients choose India for CAR-T Cell Therapy because it offers advanced cancer care when options at home are limited. The modern immunotherapy known as CAR-T Cell Therapy enables patients to use their own immune cells for treating aggressive blood cancers which include ALL, DLBCL, and specific multiple myeloma types after all other treatments have failed.
India attracts patients because it offers low-cost medical services, skilled cancer doctors, state-of-the-art healthcare equipment, and reduced patient waiting times. The medical teams who speak English, the international patient support system, and the India-based CAR-T Cell Therapy program which treats patients with empathy, make Nigerian patients choose India as their treatment destination for CART-T Cell therapy.
Types of CAR-T Cell Therapy Available in India for Nigerian Patients
Indian hospitals provide a variety of CAR-T cell therapy for Nigerian patients which they develop to meet the specific requirements of individual patients. The available treatments include:
- CD19 CAR-T therapy for treating leukaemia and lymphoma
- BCMA CAR-T therapy for multiple myeloma
- Autologous CAR-T therapy which utilizes the patient’s own T-cells
- Locally developed CAR-T products that help lower treatment costs
- Advanced CAR-T protocols which operate to improve both safety and long-term treatment results
Cost of CAR-T Cell Therapy in India for Nigerian Patients
Cost is one of the main reasons Nigerian patients choose India for CAR-T Cell Therapy. Western countries charge extremely high costs for treatment which India delivers through its advanced medical services at afordable rates.
Car-T Cell therapy estimated cost in India: USD 30,000 – 45,000 (approx.)
This cost generally includes:
- Initial consultations and medical evaluation
- T-cell collection and genetic modification
- Hospital admission and CAR-T cell infusion
- ICU monitoring if required
- Supportive medicines and post-infusion care
The final cost may vary depending on the type of cancer, CAR-T product used, hospital facilities, duration of hospital stay, and management of side effects.
Cost Comparision
- India: USD 30,000 – USD 85,000
- USA: Starts at USD 350,000 and can exceed USD 500,000
- Europe: USD 300,000 – USD 450,000
- Nigeria: USD 250,000 – over USD 4,000,000; availability is limited to private facilities and experimental sites
Key Insight: Local production of CAR-T therapy in India, combined with skilled professionals and efficient medical systems, allows significantly lower treatment costs compared to other regions
Top Hospitals in India for CAR-T Cell Therapy for Nigerian Patients
Some of the leading hospitals in India offering CAR-T Cell therapy for Nigerian patients include:
- Aakash Healthcare Super Speciality Hospital, Delhi – NABH, NABL, JCI accredited; 325-bed multi-specialty hospital
- Apollo Hospital, Ahmedabad – NABH, NABL, JCI accredited; advanced oncology and transplant services
- Fortis Hospital, Shalimar Bagh, Delhi – NABH accredited; well-known for cancer care excellence
- Manipal Hospital, Gurugram – NABH, NABL accredited; international patient-friendly infrastructure
- Max Hospital, Shalimar Bagh, Delhi – NABH, NABL accredited; advanced oncology and critical care
These hospitals follow international treatment protocols and maintain strict safety standards.
Leading Doctors in India for Nigerian Patients
Some of the experienced doctors associated with advanced cancer and cellular therapies for Nigerian patients include:
- Dr. Vinod Raina – Medical Oncology; 45+ years of experience
- Dr. Naresh Trehan – Senior specialist with decades of clinical expertise
- Dr. Randhir Sud – Specialist in complex medical cases
- Dr. Sandeep Vaishya – Known for handling advanced procedures
- Prof. Dr. Mohamed Rela – Renowned for high-risk and advanced treatments
Treatment decisions are always made by a multidisciplinary medical team.
CAR-T Cell Therapy: Journey for Nigerian Patients
- Personalized Consultation
- Travel & Logistics Support
- T-Cell Collection & Modification
- CAR-T Infusion
- Hospital Stay
- Recovery & Follow-Up
Frequently Asked Questions
- Who assesses if CAR-T Cell Therapy is suitable?
Before an oncologist suggests CAR-T therapy, they examine a patient’s medical history and test reports.
- How long does a Nigerian patient need to stay in India?
The patients will stay for a couple of weeks until all treatments are completed and the patient is safe for traveling.
- Are side effects common after CAR-T therapy?
The medical team monitors and manages the side effects which occur during treatment.
- Will language be a problem in Indian hospitals?
No,doctors and medical staff can communicate in English
- Can a family member stay with the patient during treatment?
Yes, accommodation options are available near hospitals for family members if any.
Conclusion
Nigerian patients who want advanced cancer treatment have now access to CAR-T Cell Therapy which is available in India. India provides a reliable treatment option which combines experienced medical experts, modern medical facilities and economical healthcare services to deliver life-saving treatments. The EdhaCare medical team provides complete support to patients and their families from the initial consultation until their recovery which allows them to concentrate on healing while specialists handle all treatment aspects.
Medical Disclaimer
The provided content is solely meant for informational purposes and should not be taken as professional medical advice. Always seek the opinion of a qualified onco -surgeons when deciding on a treatment option.